Research

Consumer Advisory Board members commit their time and personal experience in bringing the consumers perspective to research matters related to prevention, treatment and self-management of arthritis at the Arthritis Research Centre of Canada.

Top clinical investigators, basic scientists of virtually every stripe and consumer/activists from a variety of arthritis organizations came together for the “Frontiers in Inflammatory Joint Diseases” conference, held in Toronto from May 7–9. The conference’s ultimate goal was to set the Canadian research agenda for such chronic inflammatory diseases as rheumatoid arthritis, ankylosing spondylitis and juvenile arthritis.

The conduct of research that involves humans, including clinical trials, is guided by a set of ethical principles. These appear as guidelines that outline the duties to those who participate as research subjects. They also outline the duties, rights and norms of those engaged in research. Click here for a list of Web resources that offer more details about the duties, rights and norms of participating in human research.

The innovative research carried out by the Canadian Arthritis Network (CAN) is crucial to the health and well being of CAPA members, and of all people with arthritis.

Les patients-partenaires contre l'arthrite sont des personnes atteintes d'arthrite qui mettent leur corps au service de la science. Comment sont-ils différents des autres arthritiques? Qu'est-ce qu'ils font de spécial? Comment sont-ils perçus par les professionnels de la santé? Pour en savoir plus, cliquez.

CAPA opens the door for consumer influence at meeting of The Health Products and Food Branch meeting in Ottawa.

Ever needed to make a decision about starting a medication and wanted to know what the research says? One study says it works and another says it doesn't. The Cochrane Collaboration is trying to help.

More comprehensive in scope than previous publications of its kind, this publication, launched in September 2003, illustrates the growing service gap created by the ever-increasing number of people with arthritis.

Most Canadians are unaware that treatment and management of the more than 100 types of arthritis costs close to $17 billion annually. There is no cure for these diseases, and partnerships are an effective way of coping with this crisis.